<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-may-27-2026</loc><lastmod>2026-05-27T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – May 27, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-may-22-2026</loc><lastmod>2026-05-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer May 22, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/evaluating-car-t-miv-cel-stiff-person-syndrome</loc><lastmod>2026-05-22T13:00:56.525Z</lastmod><news:news><news:publication_date>2026-05-22T13:00:56.525Z</news:publication_date>
        <news:title><![CDATA[Evaluating Miv-Cel for Stiff Person Syndrome]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-may-20-2026</loc><lastmod>2026-05-20T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – May 20, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/phase-3-hope-3-data-reinforce-skeletal-cardiac-benefits-deramiocel-in-duchenne-muscular-dystrophy</loc><lastmod>2026-05-18T18:36:30.928Z</lastmod><news:news><news:publication_date>2026-05-18T18:36:30.928Z</news:publication_date>
        <news:title><![CDATA[Phase 3 HOPE-3 Data Reinforce Skeletal and Cardiac Benefits of Deramiocel in Duchenne Muscular Dystrophy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/assessing-miv-cel-myasthenia-gravis</loc><lastmod>2026-05-15T19:00:36.491Z</lastmod><news:news><news:publication_date>2026-05-15T19:00:36.491Z</news:publication_date>
        <news:title><![CDATA[Assessing Miv-Cel for Myasthenia Gravis ]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-may-15-2026</loc><lastmod>2026-05-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer May 15, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/asgct-2026-gs-100-gene-therapy-demonstrates-early-activity-ngly1-deficiency</loc><lastmod>2026-05-14T15:09:27.408Z</lastmod><news:news><news:publication_date>2026-05-14T15:09:27.408Z</news:publication_date>
        <news:title><![CDATA[ASGCT 2026: GS-100 Gene Therapy Demonstrates Early Activity in NGLY1 Deficiency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/etx101-gene-therapy-shows-early-developmental-seizure-benefits-dravet-syndrome</loc><lastmod>2026-05-13T20:40:01.867Z</lastmod><news:news><news:publication_date>2026-05-13T20:40:01.867Z</news:publication_date>
        <news:title><![CDATA[ETX101 Gene Therapy Shows Early Developmental, Seizure Benefits in Dravet Syndrome]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-may-13-2026</loc><lastmod>2026-05-13T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – May 13, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/beacon-therapeutics-reports-sustained-12-month-visual-gains-laru-zova-xlrp</loc><lastmod>2026-05-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Beacon Therapeutics Reports Sustained 12-Month Visual Gains With Laru-Zova in XLRP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/crawford-high-dose-nusinersen-future-sma-treatment</loc><lastmod>2026-05-08T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-08T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Thomas Crawford, MD, on High-Dose Nusinersen and the Future of SMA Treatment]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-may-8-2026</loc><lastmod>2026-05-07T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-07T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer May 8, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-may-6-2026</loc><lastmod>2026-05-06T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-06T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – May 6, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-may-1-2026</loc><lastmod>2026-05-01T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer May 1, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/muppidi-evaluating-miv-cel-myasthenia-gravis</loc><lastmod>2026-05-01T12:00:48.441Z</lastmod><news:news><news:publication_date>2026-05-01T12:00:48.441Z</news:publication_date>
        <news:title><![CDATA[Srikanth Muppidi, MD, on Evaluating Miv-Cel in Myasthenia Gravis]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-april-29-2026</loc><lastmod>2026-04-29T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – April 29, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/piquet-assessing-miv-cel-stiff-person-syndrome</loc><lastmod>2026-04-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Amanda Piquet, MD, FAAN, on Assessing Miv-Cel in Stiff Person Syndrome]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/lonvo-z-advances-toward-approval-first-in-vivo-crispr-therapy-hereditary-angioedema</loc><lastmod>2026-04-27T18:03:23.171Z</lastmod><news:news><news:publication_date>2026-04-27T18:03:23.171Z</news:publication_date>
        <news:title><![CDATA[Lonvo-z Advances Toward Approval as First In Vivo CRISPR Therapy for Hereditary Angioedema]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/regeneron-nets-accelerated-approval-fda-otoferlin-related-hearing-loss-gene-therapy-lunsotogene-parvec</loc><lastmod>2026-04-24T13:17:18.866Z</lastmod><news:news><news:publication_date>2026-04-24T13:17:18.866Z</news:publication_date>
        <news:title><![CDATA[Regeneron Nets Accelerated Approval From FDA for Otoferlin-Related Hearing Loss Gene Therapy Lunsotogene Parvec]]></news:title>
        <news:keywords><![CDATA[cell therapy,CTADS,CAR-T,Cell Therapy for Autoimmune Disease Summit,Autoimmune Disease,lupus,B-cell,cancer,oncology,clinical trial,clinical trials,collaboration,education,rheumatologists,nephrologists,hematologists,clinical trial,clinical trials]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-april-22-2026</loc><lastmod>2026-04-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – April 22, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/evaluating-gene-therapy-bb-301-opmd-related-dysphagia</loc><lastmod>2026-04-19T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-19T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/early-biomarker-signals-from-sgt-003-highlight-ongoing-progress-duchenne-gene-therapy</loc><lastmod>2026-04-17T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-17T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Early Biomarker Signals From SGT-003 Highlight Ongoing Progress in Duchenne Gene Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/reimagining-sma-treatment-salanersen-push-durable-low-frequency-therapies</loc><lastmod>2026-04-16T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-16T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Reimagining SMA Treatment: Salanersen and the Push for Durable, Low-Frequency Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-april-15-2026</loc><lastmod>2026-04-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – April 15, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-april-22-2026</loc><lastmod>2026-04-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer April 22, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/lek-fda-approval-high-dose-nusinersen-sma</loc><lastmod>2026-04-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Angela Lek, PhD, on the FDA's Approval of High-Dose Nusinersen in SMA]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,Sharon Hesterlee,Elevidys,conference preview,Duchenne muscular dystrophy,Peter Marks,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,ALS,cell therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-accepts-ultragenyx-new-bla-submission-mps-iiia-gene-therapy-ux111</loc><lastmod>2026-04-09T19:00:18.632Z</lastmod><news:news><news:publication_date>2026-04-09T19:00:18.632Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts Ultragenyx’s New BLA Submission for MPS IIIA Gene Therapy UX111]]></news:title>
        <news:keywords><![CDATA[hepatology,Wilson disease,Ultragenyx ,UX701 ,Cyprus2+ study ,NCT04884815,AAV9 gene therapy,gene therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-april-8-2026</loc><lastmod>2026-04-08T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-08T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-april-8-2026</loc><lastmod>2026-04-08T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-08T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer April 8, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/immunologic-episode-immunotherapy-high-risk-neuroblastoma-bosse</loc><lastmod>2026-04-03T19:00:06.570Z</lastmod><news:news><news:publication_date>2026-04-03T19:00:06.570Z</news:publication_date>
        <news:title><![CDATA[ImmunoLogic, Episode 9: "Rewiring Immunotherapy for High-Risk Neuroblastoma" With Kristopher R. Bosse, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-april-1-2026</loc><lastmod>2026-04-01T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – April 1, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-march-25-2026</loc><lastmod>2026-03-25T22:00:00Z</lastmod><news:news><news:publication_date>2026-03-25T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer March 25, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-march-25-2026</loc><lastmod>2026-03-25T19:00:00Z</lastmod><news:news><news:publication_date>2026-03-25T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – March 25, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/lek-scientific-priorities-shaped-2026-mda-conference</loc><lastmod>2026-03-20T22:45:39.069Z</lastmod><news:news><news:publication_date>2026-03-20T22:45:39.069Z</news:publication_date>
        <news:title><![CDATA[Angela Lek, PhD, on the Scientific Priorities that Shaped the 2026 MDA Conference]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,Sharon Hesterlee,Elevidys,conference preview,Duchenne muscular dystrophy,Peter Marks,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,ALS,cell therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-march-18-2026</loc><lastmod>2026-03-18T22:00:23.826Z</lastmod><news:news><news:publication_date>2026-03-18T22:00:23.826Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer March 18, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-march-18-2026</loc><lastmod>2026-03-18T19:00:00Z</lastmod><news:news><news:publication_date>2026-03-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – March 18, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/brandsema-real-world-givinostat-dmd</loc><lastmod>2026-03-18T17:30:52.768Z</lastmod><news:news><news:publication_date>2026-03-18T17:30:52.768Z</news:publication_date>
        <news:title><![CDATA[John F. Brandsema, MD, on the Real-World Use of Givinostat in DMD]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/banks-evaluating-gene-therapy-bb-301-opmd-related-dysphagia</loc><lastmod>2026-03-13T15:00:32.493Z</lastmod><news:news><news:publication_date>2026-03-13T15:00:32.493Z</news:publication_date>
        <news:title><![CDATA[Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-march-11-2026</loc><lastmod>2026-03-11T19:00:00Z</lastmod><news:news><news:publication_date>2026-03-11T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – March 11, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/crowley-future-neuromuscular-care</loc><lastmod>2026-03-11T18:16:20.243Z</lastmod><news:news><news:publication_date>2026-03-11T18:16:20.243Z</news:publication_date>
        <news:title><![CDATA[John F. Crowley, JD, MBA, on the Future of Neuromuscular Care]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-peels-back-crl-capricor-dmd-cardiomyopathy-cell-therapy-deramiocel</loc><lastmod>2026-03-10T22:00:00Z</lastmod><news:news><news:publication_date>2026-03-10T22:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Peels Back CRL on Capricor's DMD Cardiomyopathy Cell Therapy Deramiocel]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/phase-forward-53-trial-reports-sustained-dystrophin-expression-wve-n531-duchenne-muscular-dystrophy</loc><lastmod>2026-03-09T21:20:35.559Z</lastmod><news:news><news:publication_date>2026-03-09T21:20:35.559Z</news:publication_date>
        <news:title><![CDATA[Phase 2 FORWARD-53 Trial Reports Sustained Dystrophin Expression With WVE-N531 in Duchenne Muscular Dystrophy]]></news:title>
        <news:keywords><![CDATA[Wave Life Sciences,CTA,Alpha-1 Antitrypsin Deficiency,AATD,RNA editing oligonucleotide,RNA therapy,liver,lung,WVE-006,WVE-004,NCT04931862,SERPINA1,lungs,RNA Editing Therapy,GSK]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-march-4-2026</loc><lastmod>2026-03-04T20:00:00Z</lastmod><news:news><news:publication_date>2026-03-04T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – March 4, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/practical-considerations-implementing-scd-gene-therapy-clinical</loc><lastmod>2026-03-04T12:00:17.080Z</lastmod><news:news><news:publication_date>2026-03-04T12:00:17.080Z</news:publication_date>
        <news:title><![CDATA[Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-february-25-2026</loc><lastmod>2026-02-25T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-25T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer February 25, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-february-25-2026</loc><lastmod>2026-02-25T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-25T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – February 25, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/miller-integrating-gene-therapy-clinical-care-sickle-cell-disease</loc><lastmod>2026-02-25T14:00:39.861Z</lastmod><news:news><news:publication_date>2026-02-25T14:00:39.861Z</news:publication_date>
        <news:title><![CDATA[Robin E. Miller, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease]]></news:title>
        <news:keywords><![CDATA[hemgenix,etranadez,steven pipe, md,mott cs children's hospital,ASH 2023,factor IX,gene therapy,etranacogene dezaparvovec,HOPE B trial,bleeding events,hemophilia b]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/mda-upcoming-2026-clinical-scientific-conference</loc><lastmod>2026-02-22T14:00:00Z</lastmod><news:news><news:publication_date>2026-02-22T14:00:00Z</news:publication_date>
        <news:title><![CDATA[MDA’s Upcoming 2026 Clinical & Scientific Conference]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-february-18-2026</loc><lastmod>2026-02-18T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-18T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – February 18, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-february-18-2026</loc><lastmod>2026-02-18T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-18T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer February 18, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/byrne-mda-upcoming-2026-clinical-scientific-conference</loc><lastmod>2026-02-17T17:11:47.180Z</lastmod><news:news><news:publication_date>2026-02-17T17:11:47.180Z</news:publication_date>
        <news:title><![CDATA[Barry J Byrne, MD, PhD, on MDA’s Upcoming 2026 Clinical & Scientific Conference]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,conference preview,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,care centers,MDA care centers]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-february-13-2026</loc><lastmod>2026-02-13T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-13T20:00:00Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – February 13, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-february-11-2026</loc><lastmod>2026-02-11T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-11T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer February 11, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-february-11-2026</loc><lastmod>2026-02-11T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-11T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/immunologic-episode-surgery-meets-immunotherapy-breast-cancer-tchou</loc><lastmod>2026-02-10T23:03:12.605Z</lastmod><news:news><news:publication_date>2026-02-10T23:03:12.605Z</news:publication_date>
        <news:title><![CDATA[ImmunoLogic, Episode 8: "Surgery Meets Immunotherapy: A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/american-college-of-physicians-calls-for-an-end-of-the-term-provider-in-policy-paper</loc><lastmod>2026-02-10T16:16:01.345Z</lastmod><news:news><news:publication_date>2026-02-10T16:16:01.345Z</news:publication_date>
        <news:title><![CDATA[American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper]]></news:title>
        <news:keywords><![CDATA[wet AMD,gene therapy,4D-150,4d molecular therapeutics,aflibercept,PRISM,anti-VEGF,wet age-related macular degeneration,NCT05197270,antiVEGF,4D]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-slams-regenxbio-mps-ii-gene-therapy-rgx-121-crl</loc><lastmod>2026-02-10T00:08:23.068Z</lastmod><news:news><news:publication_date>2026-02-10T00:08:23.068Z</news:publication_date>
        <news:title><![CDATA[FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/ultragenyx-puts-bla-mps-iiia-gene-therapy-ux111-front-fda-again</loc><lastmod>2026-02-06T16:00:47.987Z</lastmod><news:news><news:publication_date>2026-02-06T16:00:47.987Z</news:publication_date>
        <news:title><![CDATA[Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again]]></news:title>
        <news:keywords><![CDATA[hepatology,Wilson disease,Ultragenyx ,UX701 ,Cyprus2+ study ,NCT04884815,AAV9 gene therapy,gene therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-february-4-2026</loc><lastmod>2026-02-04T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-04T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer February 4, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-february-4-2026</loc><lastmod>2026-02-04T20:00:00Z</lastmod><news:news><news:publication_date>2026-02-04T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – February 4, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-january-30-2026</loc><lastmod>2026-01-30T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-30T20:00:00Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – January 30, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/pivotal-trial-taysha-rett-syndrome-gene-therapy-tsha-102-doses-first-patient</loc><lastmod>2026-01-30T14:00:00Z</lastmod><news:news><news:publication_date>2026-01-30T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Pivotal Trial for Taysha's Rett Syndrome Gene Therapy TSHA-102 Doses First Patient]]></news:title>
        <news:keywords><![CDATA[wet AMD,gene therapy,4D-150,4d molecular therapeutics,aflibercept,PRISM,anti-VEGF,wet age-related macular degeneration,NCT05197270,antiVEGF,4D]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/ocugen-gene-therapy-ocu410st-continues-efficacy-phase-stargardt-disease-trial</loc><lastmod>2026-01-29T14:00:00Z</lastmod><news:news><news:publication_date>2026-01-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Ocugen’s Gene Therapy OCU410ST Continues to Show Efficacy in Phase 1 Stargardt Disease Trial]]></news:title>
        <news:keywords><![CDATA[wet AMD,gene therapy,4D-150,4d molecular therapeutics,aflibercept,PRISM,anti-VEGF,wet age-related macular degeneration,NCT05197270,antiVEGF,4D]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-january-28-2026</loc><lastmod>2026-01-28T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-28T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – January 28, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/integrating-gene-therapy-clinical-care-hemophilia-b</loc><lastmod>2026-01-27T12:00:25.222Z</lastmod><news:news><news:publication_date>2026-01-27T12:00:25.222Z</news:publication_date>
        <news:title><![CDATA[Integrating Gene Therapy into Clinical Care for Hemophilia B]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-january-23-2026</loc><lastmod>2026-01-23T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-23T20:00:00Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – January 23, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/goldberg-potential-cell-gene-therapy-glaucoma</loc><lastmod>2026-01-22T21:51:14.452Z</lastmod><news:news><news:publication_date>2026-01-22T21:51:14.452Z</news:publication_date>
        <news:title><![CDATA[Jeffrey Goldberg, MD, PhD, on the Potential of Cell and Gene Therapy in Glaucoma]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-january-21-2026</loc><lastmod>2026-01-21T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-21T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – January 21, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-january-21-2026</loc><lastmod>2026-01-21T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-21T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer January 21, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/ocugen-positive-preliminary-phase-2-armada-trial-data-ocu410</loc><lastmod>2026-01-20T18:00:07.665Z</lastmod><news:news><news:publication_date>2026-01-20T18:00:07.665Z</news:publication_date>
        <news:title><![CDATA[Ocugen Posts Positive Preliminary Phase 2 ArMaDa Trial Data of OCU410]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-january-16-2026</loc><lastmod>2026-01-16T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-16T20:00:00Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – January 16, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/therapies-watch-1h-2026</loc><lastmod>2026-01-15T16:00:34.912Z</lastmod><news:news><news:publication_date>2026-01-15T16:00:34.912Z</news:publication_date>
        <news:title><![CDATA[Therapies to Watch in 1H 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-january-14-2026</loc><lastmod>2026-01-14T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-14T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer January 14, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-january-14-2026</loc><lastmod>2026-01-14T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-14T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – January 14, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/lin-using-genetics-biomarkers-clinical-trial-readiness-enhance-als-care</loc><lastmod>2026-01-13T22:34:08.095Z</lastmod><news:news><news:publication_date>2026-01-13T22:34:08.095Z</news:publication_date>
        <news:title><![CDATA[Brian Lin, PhD, on Using Genetics, Biomarkers, and Clinical Trial Readiness to Enhance ALS Care]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,Sharon Hesterlee,Elevidys,conference preview,Duchenne muscular dystrophy,Peter Marks,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,ALS,cell therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/pipe-integrating-gene-therapy-clinical-care-hemophilia-b</loc><lastmod>2026-01-13T19:00:27.327Z</lastmod><news:news><news:publication_date>2026-01-13T19:00:27.327Z</news:publication_date>
        <news:title><![CDATA[Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B]]></news:title>
        <news:keywords><![CDATA[hemgenix,etranadez,steven pipe, md,mott cs children's hospital,ASH 2023,factor IX,gene therapy,etranacogene dezaparvovec,HOPE B trial,bleeding events,hemophilia b]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/data-roundup-december-2025-features-updates-ash-ctad</loc><lastmod>2026-01-12T20:00:20.033Z</lastmod><news:news><news:publication_date>2026-01-12T20:00:20.033Z</news:publication_date>
        <news:title><![CDATA[Data Roundup: December 2025 Features Updates from ASH and CTAD]]></news:title>
        <news:keywords><![CDATA[age-related macular degeneration,neurology,gi cancer,frontotemporal dementia,epilepsy,satri-cel,parkinson disease,cell therapy,gene therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-hits-atara-biotherapeutics-t-cell-immunotherapy-tabelecleucel-ebv-ptld-second-crl</loc><lastmod>2026-01-12T14:13:37.777Z</lastmod><news:news><news:publication_date>2026-01-12T14:13:37.777Z</news:publication_date>
        <news:title><![CDATA[FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/lek-priorities-agenda-mda-2026-conference</loc><lastmod>2026-01-11T14:00:00Z</lastmod><news:news><news:publication_date>2026-01-11T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Angela Lek, PhD, on the Priorities and Agenda for MDA's 2026 Conference]]></news:title>
        <news:keywords><![CDATA[mda,MDA 2024 meeting,gene therapy,muscular dystrophy association,Sharon Hesterlee,Elevidys,conference preview,Duchenne muscular dystrophy,Peter Marks,neuromuscular disorders,neuromuscular disease,MDA 2024,Clinical & Scientific Conference,ALS,cell therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-january-9-2026</loc><lastmod>2026-01-09T20:00:44.604Z</lastmod><news:news><news:publication_date>2026-01-09T20:00:44.604Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – January 9, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/interview-highlights-ash-2025-meeting</loc><lastmod>2026-01-08T19:00:11.578Z</lastmod><news:news><news:publication_date>2026-01-08T19:00:11.578Z</news:publication_date>
        <news:title><![CDATA[Interview Highlights From ASH's 2025 Meeting]]></news:title>
        <news:keywords><![CDATA[hemgenix,etranadez,steven pipe, md,mott cs children's hospital,ASH 2023,factor IX,gene therapy,etranacogene dezaparvovec,HOPE B trial,bleeding events,hemophilia b]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/guess-the-therapy-answer-january-7-2026</loc><lastmod>2026-01-07T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-07T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Guess the Therapy Answer January 7, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/around-the-helix-cell-and-gene-therapy-company-updates-january-7-2026</loc><lastmod>2026-01-07T20:00:00Z</lastmod><news:news><news:publication_date>2026-01-07T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Around the Helix: Cell and Gene Therapy Company Updates – January 7, 2026]]></news:title>
        <news:keywords><![CDATA[cell therapy,gene therapy,FDA,IND,investigational new drug application,allogeneic,solid tumors,gene editing,clinical trial,AAV,solid tumors,orphan drug designation,CDMO,PDUFA,collaboration,BLA,helix,Around the Helix]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-activity-recap-december-2025-features-multiple-approvals-rmat-designation-more</loc><lastmod>2026-01-07T16:35:45.150Z</lastmod><news:news><news:publication_date>2026-01-07T16:35:45.150Z</news:publication_date>
        <news:title><![CDATA[FDA Activity Recap: December 2025 Features Multiple Approvals, RMAT Designation, and More]]></news:title>
        <news:keywords><![CDATA[FDA news,FDA ,FDA decisions ,FDA activity,FDA roundup,CAR T cell therapy,FDA January 2024,Casgevy,transfusion-dependent beta thalassemia,Black Box Warning,guidance documents,Axi-Cel,cilta-cel]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/fda-decisions-look-1h-2026</loc><lastmod>2026-01-06T21:54:38.063Z</lastmod><news:news><news:publication_date>2026-01-06T21:54:38.063Z</news:publication_date>
        <news:title><![CDATA[FDA Decisions to Look For in 1H 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/integrating-ai-tools-clinical-practice-genetic-counselors</loc><lastmod>2026-01-06T16:10:04.682Z</lastmod><news:news><news:publication_date>2026-01-06T16:10:04.682Z</news:publication_date>
        <news:title><![CDATA[Integrating AI Tools Into Clinical Practice for Genetic Counselors]]></news:title>
        <news:keywords><![CDATA[cell therapy,CTADS,CAR-T,Cell Therapy for Autoimmune Disease Summit,Autoimmune Disease,lupus,B-cell,cancer,oncology,clinical trial,clinical trials,collaboration,education,rheumatologists,nephrologists,hematologists,clinical trial,clinical trials]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/ultragenyx-finishes-rolling-submission-bla-glycogen-storage-disease-gene-therapy-dtx401</loc><lastmod>2026-01-05T19:00:51.381Z</lastmod><news:news><news:publication_date>2026-01-05T19:00:51.381Z</news:publication_date>
        <news:title><![CDATA[Ultragenyx Finishes Rolling Submission of BLA for Glycogen Storage Disease Gene Therapy DTX401]]></news:title>
        <news:keywords><![CDATA[hepatology,Wilson disease,Ultragenyx ,UX701 ,Cyprus2+ study ,NCT04884815,AAV9 gene therapy,gene therapy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/impact-artificial-intelligence-cell-gene-therapy</loc><lastmod>2026-01-04T14:00:00Z</lastmod><news:news><news:publication_date>2026-01-04T14:00:00Z</news:publication_date>
        <news:title><![CDATA[The Impact of Artificial Intelligence on Cell and Gene Therapy]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/pillars-progress-top-news-oncology-2025</loc><lastmod>2026-01-03T22:00:00Z</lastmod><news:news><news:publication_date>2026-01-03T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Pillars of Progress: Top News in Oncology From 2025]]></news:title>
        <news:keywords><![CDATA[Cell and gene therapy,Cell and gene therapy conferences,2023 medical society meetings,AHA 2023,ASCO 2023,ESGCT 2023,AACR 2023,WORLDSymposium 2023,ASGCT 2023]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/immunologic-bonus-episode-chemo-optional-data-mandatory-year-end-recap</loc><lastmod>2026-01-02T19:30:57.548Z</lastmod><news:news><news:publication_date>2026-01-02T19:30:57.548Z</news:publication_date>
        <news:title><![CDATA[ImmunoLogic, Bonus Episode: "Chemo Optional, Data Mandatory - A Year-End Recap"]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/reducing-costs-goods-cell-gene-therapy</loc><lastmod>2025-12-30T14:00:00Z</lastmod><news:news><news:publication_date>2025-12-30T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Reducing Costs of Goods in Cell and Gene Therapy]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/future-predictions-field-cell-gene-therapy</loc><lastmod>2025-12-29T14:00:00Z</lastmod><news:news><news:publication_date>2025-12-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Future Predictions for the Field of Cell and Gene Therapy]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/top-fda-gene-cell-therapy-news-2025-year-end-recap</loc><lastmod>2025-12-27T14:00:00Z</lastmod><news:news><news:publication_date>2025-12-27T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Top FDA Gene and Cell Therapy News: 2025 Year-End Recap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/immunologic-bonus-episode-ash-2025-practice-changers-ground-wi-fi</loc><lastmod>2025-12-24T20:00:00Z</lastmod><news:news><news:publication_date>2025-12-24T20:00:00Z</news:publication_date>
        <news:title><![CDATA[ImmunoLogic, Bonus Episode: "ASH 2025: Practice-Changers on the Ground and on the Wi‑Fi"]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/rutgers-iovance-assess-e7-tcr-t-cell-therapy-phase-trial-hpv-associated-tumors</loc><lastmod>2025-12-22T23:00:00Z</lastmod><news:news><news:publication_date>2025-12-22T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Rutgers Assesses E7 TCR T-Cell Therapy in Phase 1/2 Trial for HPV-Associated Tumors]]></news:title>
        <news:keywords><![CDATA[Clinical Trials in Progress,hearing loss,gene therapy,OTOF-Mediated Hearing Loss,OTOF,otoferlin,Akouos,AK-OTOF,NCT05821959,AK-OTOF-101,AK-OTOF-NHS-002,NCT05572073,ARO]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/cgtlive-weekly-rewind-december-19-2025</loc><lastmod>2025-12-19T20:00:00Z</lastmod><news:news><news:publication_date>2025-12-19T20:00:00Z</news:publication_date>
        <news:title><![CDATA[CGTLive®’s Weekly Rewind – December 19, 2025]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/sangamo-bla-fabry-disease-gene-therapy-isa-vec-front-fda</loc><lastmod>2025-12-19T19:51:18.848Z</lastmod><news:news><news:publication_date>2025-12-19T19:51:18.848Z</news:publication_date>
        <news:title><![CDATA[Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/implications-final-data-hemgenix-hope-b-trial</loc><lastmod>2025-12-18T19:00:54.374Z</lastmod><news:news><news:publication_date>2025-12-18T19:00:54.374Z</news:publication_date>
        <news:title><![CDATA[The Implications of the Final Data From Hemgenix’s HOPE-B Trial]]></news:title>
        <news:keywords><![CDATA[Deborah Phippard,Precision for Medicine,Precision,gene therapy,CNS,central nervous system,AAV,neurological indications,neurology indications,future,Alzheimer disease,Parkinson disease,Alzheimer's disease,Parkinson's disease,delivery,diagnostic tools,artificial intelligence,AI,AI tools]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.cgtlive.com/view/brown-models-expanding-access-cardiac-genetic-counseling</loc><lastmod>2025-12-18T13:00:23.679Z</lastmod><news:news><news:publication_date>2025-12-18T13:00:23.679Z</news:publication_date>
        <news:title><![CDATA[Emily Brown, MGC, CGC, on Models for Expanding Access to Cardiac Genetic Counseling]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>